{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T17:20:43Z","timestamp":1695835243996},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1982,3,1]],"date-time":"1982-03-01T00:00:00Z","timestamp":383788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1982,3]]},"DOI":"10.1007\/bf01243516","type":"journal-article","created":{"date-parts":[[2005,2,26]],"date-time":"2005-02-26T10:42:00Z","timestamp":1109414520000},"page":"7-21","source":"Crossref","is-referenced-by-count":9,"title":["Hypothalamic-pituitary dopaminergic function in hepatic failure in man"],"prefix":"10.1007","volume":"53","author":[{"given":"S.","family":"Lal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Oravec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Aronoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Kiely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Guyda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. P. V.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1210\/jcem-34-2-312","volume":"34","author":"G. E. Abraham","year":"1972","unstructured":"Abraham, G. E., Odell, W. D., Swerdloff, R. S., Hopper, K.: Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17 beta during the menstrual cycle. J. Clin. Endocr. Metab.34, 312?318 (1972).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR2","first-page":"188","volume":"75","author":"O. Abramsky","year":"1974","unstructured":"Abramsky, O., Goldschmidt, Z.: Treatment and prevention of acute hepatic encephalopathy by intravenous levodopa. Surgery75, 188?193 (1974).","journal-title":"Surgery"},{"key":"CR3","first-page":"145","volume":"45","author":"H. W. G. Baker","year":"1976","unstructured":"Baker, H. W. G., Burger, H. G., de Kretser, D. M., Dulmanis, A., Hudson, B., O'Connor, S., Paulsen, C. A., Purcell, N., Rennie, G. C., Seah, C. S., Taft, H. P., Wang, C.: A study of the endocrine manifestations of hepatic cirrhosis. Quart. J. Med.45, 145?178 (1976).","journal-title":"Quart. J. Med."},{"key":"CR4","first-page":"175","volume":"133","author":"M. Baldy-Moulinier","year":"1977","unstructured":"Baldy-Moulinier, M., Bories, P., Michel, H., Passouant, P.: Enc\u00e9phalopathies h\u00e9patiques; \u00e9tude h\u00e9modynamique et m\u00e9tabolique de l'influence de l'ammoniaque et de la L-dopa. Rev. Neurol.133, 175?189 (1977).","journal-title":"Rev. Neurol."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/pgmj.53.619.262","volume":"53","author":"T. Chajek","year":"1977","unstructured":"Chajek, T., Berry, E. M., Friedman, G., Abramsky, O.: Treatment of acute hepatic encephalopathy with L-dopa. Postgrad. Med. J.53, 262?265 (1977).","journal-title":"Postgrad. Med. J."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1542\/peds.51.6.1105b","volume":"51","author":"A. R. Colon","year":"1973","unstructured":"Colon, A. R., Sandberg, D. H.: Hepatic encephalopathy treated with L-dopa, recovery followed for 18 months. Pediatrics51, 1105?1106 (1973).","journal-title":"Pediatrics"},{"key":"CR7","first-page":"678","volume":"76","author":"H. O. Conn","year":"1970","unstructured":"Conn, H. O., Daughaday, W. H.: Cirrhosis and diabetes. V. Serum growth hormone levels in Laennec's cirrhosis. J. Lab. Clin. Med.76, 678?688 (1970).","journal-title":"J. Lab. Clin. Med."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/gut.21.7.565","volume":"21","author":"G. Cuilleret","year":"1980","unstructured":"Cuilleret, G., Pomier-Layrargues, G., Pons, F., Cadilhac, J., Michel, H.: Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy. Gut21, 565?569 (1980).","journal-title":"Gut"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/jnnp.38.8.794","volume":"38","author":"A. Elithorn","year":"1975","unstructured":"Elithorn, A., Lunzer, M., Weinman, J.: Cognitive deficits associated with chronic hepatic encephalopathy and their response to levodopa. J. Neurol. Neurosurg. Psychiat.38, 794?798 (1975).","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1210\/jcem-40-6-1094","volume":"40","author":"P. Ettigi","year":"1975","unstructured":"Ettigi, P., Lal, S., Martin, J. B., Friesen, H. G.: Effect of sex, oral contraceptives and glucose loading on apomorphine-induced growth hormone secretion. J. Clin. Endocr. Metab.40, 1094?1098 (1975).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp.39.9.870","volume":"39","author":"P. Ettigi","year":"1976","unstructured":"Ettigi, P., Nair, N. P. V., Lal, S., Cervantes, P., Guyda, H.: Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy. J. Neurol. Neurosurg. Psychiat.39, 870?876 (1976).","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(71)92048-4","volume":"2","author":"J. E. Fischer","year":"1971","unstructured":"Fischer, J. E., Baldessarini, R. J.: False neurotransmitters and hepatic failure. Lancet2, 75?79 (1971).","journal-title":"Lancet"},{"key":"CR13","first-page":"363","volume":"5","author":"J. E. Fischer","year":"1976","unstructured":"Fischer, J. E., Baldessarini, R. J.: Pathogenesis and therapy of hepatic coma. Progr. Liv. Dis.5, 363?397 (1976).","journal-title":"Progr. Liv. Dis."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00000658-197604000-00010","volume":"183","author":"J. E. Fischer","year":"1976","unstructured":"Fischer, J. E., Funovics, J. M., Falcao, H. A., Wesdorp, R. I. C.: L-Dopa in hepatic coma. Ann. Surg.183, 386?391 (1976).","journal-title":"Ann. Surg."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/jcem-31-6-611","volume":"31","author":"H. G. Friesen","year":"1970","unstructured":"Friesen, H. G., Guyda, H., Hardy, J.: Biosynthesis of human growth hormone and prolactin. J. Clin. Endocr. Metab.31, 611?624 (1970).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR16","first-page":"560","volume":"127","author":"P. E. Girard","year":"1972","unstructured":"Girard, P. E., Trillet, M., Kopp, N.: Correction par L-dopa des manifestations neurologiques d'une enc\u00e9phalopathie porto-cave chronique. Rev. Neurol.127, 560?563 (1972).","journal-title":"Rev. Neurol."},{"key":"CR17","first-page":"25","volume":"73","author":"A. Hernandez","year":"1969","unstructured":"Hernandez, A., Zorrilla, E., Gershberg, H.: Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease. J. Lab. Clin. Med.73, 25?33 (1969).","journal-title":"J. Lab. Clin. Med."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jcem-30-5-615","volume":"30","author":"R. Illig","year":"1970","unstructured":"Illig, R., Prader, A.: Effect of testosterone on growth hormone secretion in patients with anorchia and delayed puberty. J. Clin. Endocr. Metab.30, 615?618 (1970).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01252022","volume":"41","author":"K. Jellinger","year":"1977","unstructured":"Jellinger, K., Riederer, P.: Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study on human postmortem material. J. Neural Transm.41, 275?286 (1977).","journal-title":"J. Neural Transm."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00684999","volume":"43","author":"K. Jellinger","year":"1978","unstructured":"Jellinger, K., Riederer, P., Kleinberger, G., Wuketich, St., Kothbauer, B.: Brain monoamines in human hepatic encephalopathy. Acta Neuropathol. (Berl.)43, 63?68 (1978).","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"CR21","first-page":"868","volume":"62","author":"A. D. Jorge","year":"1973","unstructured":"Jorge, A. D., Sanchez, D.: Die Wirkung des L-Dopa im Coma hepaticum. Schweiz. Rundschau Med.62, 868?872 (1973).","journal-title":"Schweiz. Rundschau Med."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/jcem-43-3-557","volume":"43","author":"H. K. Kley","year":"1976","unstructured":"Kley, H. K., Keck, E., Kruskemper, H. L.: Estrone and estradiol in patients with cirrhosis of the liver: effects of ACTH and dexamethasone. J. Clin. Endocr. Metab.43, 557?560 (1976).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bmj.1.5907.549","volume":"1","author":"A. J. Knell","year":"1974","unstructured":"Knell, A. J., Davidson, A. R., Williams, R., Kantamaneni, B. D., Curzon, G.: Dopamine and serotonin metabolism in hepatic encephalopathy. Brit. Med. J.1, 549?551 (1974).","journal-title":"Brit. Med. J."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(72)93061-9","volume":"2","author":"S. Lal","year":"1972","unstructured":"Lal, S., de la Vega, C. E., Sourkes, T. L., Friesen, H. G.: Effect of apomorphine on human growth hormone secretion. Lancet2, 661 (1972).","journal-title":"Lancet"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/jcem-37-5-719","volume":"37","author":"S. Lal","year":"1973","unstructured":"Lal, S., de la Vega, C. E., Sourkes, T. L., Friesen, H. G.: Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum. J. Clin. Endocr. Metab.37, 719?724 (1973).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0303-8467(74)80006-5","volume":"77","author":"S. Lal","year":"1974","unstructured":"Lal, S., Aronoff, A., Garelis, E., Sourkes, T. L., Young, S. N., de la Vega, C. E.: Cerebrospinal fluid homovanillic acid, 5-hydroxyindoacetic acid, lactic acid, and pH before and after probenecid in hepatic coma. Clin. Neurol. Neurosurg.77, 142?154 (1974).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2265.1975.tb01535.x","volume":"4","author":"S. Lal","year":"1975","unstructured":"Lal, S., Martin, J. B., de la Vega, C. E., Friesen, H. G.: Comparison of the effect of apomorphine and L-dopa on serum growth hormone levels in normal men. Clin. Endocr.4, 277?285 (1975).","journal-title":"Clin. Endocr."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1210\/jcem-44-4-766","volume":"44","author":"S. Lal","year":"1977","unstructured":"Lal, S., Guyda, H., Bikadoroff, S.: Effect of methysergide and pimozide on apomorphine-induced growth hormone secretion in men. J. Clin. Endocr. Metab.44, 766?770 (1977).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0447.1978.tb06876.x","volume":"57","author":"S. Lal","year":"1978","unstructured":"Lal, S., Nair, N. P. V., Guyda, H.: Effect of lithium on hypothalamic-pituitary dopaminergic function. Acta Psychiat. Scand.57, 91?96 (1978).","journal-title":"Acta Psychiat. Scand."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-0447.1979.tb06959.x","volume":"59","author":"S. Lal","year":"1979","unstructured":"Lal, S., Nair, N. P. V., Cervantes, P., Pulman, J., Guyda, H.: Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion. Acta Psychiat. Scand.59, 173?179 (1979).","journal-title":"Acta Psychiat. Scand."},{"key":"CR31","unstructured":"Lal, S., Nair, N. P. V., Cervantes, P., Guyda, H.: Use of drug-induced growth hormone and prolactin responses in psychiatric research. In: Progress in Psychoneuroendocrinology (Brambilla, F., Racagni, G., de Wied, D., eds.), pp.295?307. Elsevier-North Holland Biomedical Press. 1980."},{"key":"CR32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01254911","volume":"50","author":"S. Lal","year":"1981","unstructured":"Lal, S., Etienne, P., Thavundayil, J., Nair, N. P. V., Collier, B., Rastogi, R., Guyda, H., Schwartz, G.: Effect of choline on central dopaminergic function in normal subjects. J. Neural Transm.50, 29?37 (1981 a).","journal-title":"J. Neural Transm."},{"key":"CR33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01254912","volume":"50","author":"S. Lal","year":"1981","unstructured":"Lal, S., Thavundayil, J., Nair, N. P. V., Etienne, P., Rastogi, R., Schwartz, G., Pulman, J., Guyda, H.: Effect of sleep deprivation on dopamine receptor function in normal subjects. J. Neural Transm.50, 39?45 (1981 b).","journal-title":"J. Neural Transm."},{"key":"CR34","first-page":"364","volume":"79","author":"T. A. Louidice","year":"1979","unstructured":"Louidice, T. A., Tulman, A., Buhac, I.: L-Dopa and hepatic encephalopathy. New Y. St. J. Med.79, 364?366 (1979).","journal-title":"New Y. St. J. Med."},{"key":"CR35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/gut.15.7.555","volume":"15","author":"M. Lunzer","year":"1974","unstructured":"Lunzer, M., James, I. M., Weinman, J., Sherlock, S.: Treatment of chronic hepatic encephalopathy with levodopa. Gut15, 555?561 (1974).","journal-title":"Gut"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jcem-40-1-162","volume":"40","author":"I. Maany","year":"1975","unstructured":"Maany, I., Frazer, A., Mendels, J.: Apomorphine: effect on growth hormone. J. Clin. Endocr. Metab.40, 162?163 (1975).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jcem-28-3-425","volume":"28","author":"L. G. Martin","year":"1968","unstructured":"Martin, L. G., Clark, J. W., Connor, T. B.: Growth hormone secretion enhanced by androgens. J. Clin. Endocr. Metab.28, 425?428 (1968).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR38","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/jcem-33-6-896","volume":"33","author":"T. J. Merimee","year":"1971","unstructured":"Merimee, T. J., Fineberg, S. E.: Studies of the sex based variation of human growth hormone secretion. J. Clin. Endocr. Metab.33, 896?902 (1971).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR39","first-page":"232","volume":"15","author":"H. Michel","year":"1977","unstructured":"Michel, H., Cauvet, G., Granier, P. M., Bali, J. P., Andre, R., Cuilleret, G.: Treatment of cirrhotic hepatic encephalopathy by l-dopa. A double-blind study of 58 patients. Digestion15, 232?233 (1977).","journal-title":"Digestion"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0016-5085(80)90132-8","volume":"79","author":"H. Michel","year":"1980","unstructured":"Michel, H., Solere, M., Granier, G., Cauvet, G., Bali, J. P., Pons, F., Bellet-Hermann, H.: Treatment of chronic hepatic encephalopathy with L-dopa. A control trial. Gastroenterology79, 207?211 (1980).","journal-title":"Gastroenterology"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0014-2999(73)90183-0","volume":"22","author":"K. Missala","year":"1973","unstructured":"Missala, K., Lal, S., Sourkes, T. L.: O-Methylation of apomorphine and the metabolic prolongation of apomorphine-induced stereotyped behaviour. Europ. J. Pharmacol.22, 54?58 (1973).","journal-title":"Europ. J. Pharmacol."},{"key":"CR42","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM197704072961406","volume":"296","author":"M. Y. Morgan","year":"1977","unstructured":"Morgan, M. Y., Jakobovits, A. W., Elithorn, A., James, I. M., Sherlock, S.: Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathy. New Engl. J. Med.296, 793?794 (1977).","journal-title":"New Engl. J. Med."},{"key":"CR43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0016-5085(80)90665-4","volume":"78","author":"M. Y. Morgan","year":"1980","unstructured":"Morgan, M. Y., Jakobovits, A. W., James, I. M., Sherlock, S.: Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology78, 663?670 (1980).","journal-title":"Gastroenterology"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000117675","volume":"5","author":"N. P. V. Nair","year":"1979","unstructured":"Nair, N. P. V., Lal, S., Cervantes, P., Yassa, R., Guyda, H.: Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia. Neuropsychobiol.5, 136?142 (1979).","journal-title":"Neuropsychobiol."},{"key":"CR45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1530\/acta.0.0800230","volume":"80","author":"K. O. Nilsson","year":"1975","unstructured":"Nilsson, K. O.: Lack of effect of hyperglycaemia on apomorphine-induced growth hormone release in normal man. Acta Endocrinol. (Kbh.)80, 230?236 (1975).","journal-title":"Acta Endocrinol. (Kbh.)"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/jcem-45-1-134","volume":"45","author":"A. E. Panerai","year":"1977","unstructured":"Panerai, A. E., Salerno, F., Manneschi, M., Cocchi, D., M\u00fcller, E. E.: Growth hormone and prolactin responses to thyrotropin-releasing hormone in patients with severe liver disease. J. Clin. Endocr. Metab.45, 134?140 (1977).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR47","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(70)92362-7","volume":"2","author":"J. D. Parkes","year":"1970","unstructured":"Parkes, J. D., Sharpstone, P., Williams, R.: Levodopa in hepatic coma. Lancet2, 1341?1343 (1970).","journal-title":"Lancet"},{"key":"CR48","first-page":"161","volume":"37","author":"J. H. Peniche","year":"1972","unstructured":"Peniche, J. H., Posada, J. C. G., Arroyave, S. T.: Coma hepatico. Tratamiento con L-dopa. Comunicacion preliminar. Prensa Med. Mexicana37, 161?162 (1972).","journal-title":"Prensa Med. Mexicana"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1210\/jcem-41-2-392","volume":"41","author":"B. L. Pimstone","year":"1975","unstructured":"Pimstone, B. L., Le Roith, D., Epstein, S., Kronheim, S.: Disappearance rates of plasma growth hormone after intravenous somatostatin in renal and liver disease. J. Clin. Endocr. Metab.41, 392?395 (1975).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR50","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJM197303292881302","volume":"288","author":"S. Podolsky","year":"1973","unstructured":"Podolsky, S., Zimmerman, H. J., Burrows, B. A., Cardarelli, J. A., Pattavina, C. G.: Potassium depletion in hepatic cirrhosis. A reversible cause of impaired growth hormone and insulin response to stimulation. New Engl. J. Med.288, 644?648 (1973).","journal-title":"New Engl. J. Med."},{"key":"CR51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archinte.1969.00300180021004","volume":"124","author":"N. A. Samaan","year":"1969","unstructured":"Samaan, N. A., Stone, D. B., Eckhardt, R. D.: Serum glucose, insulin and growth hormone in chronic hepatic cirrhosis. Arch. Int. Med.124, 149?152 (1969).","journal-title":"Arch. Int. Med."},{"key":"CR52","first-page":"2226","volume":"79","author":"A. Sarrazin","year":"1971","unstructured":"Sarrazin, A., Emerit, J., Olivier, L., Rebelo, F., Bousquet, O.: Traitement du coma h\u00e9patique par l-dopa. Premiers r\u00e9sultats. Presse M\u00e9d.79, 2226?2227 (1971).","journal-title":"Presse M\u00e9d."},{"key":"CR53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-4757-4395-1_7","volume":"1","author":"T. L. Sourkes","year":"1975","unstructured":"Sourkes, T. L., Lal, S.: Apomorphine and its relation to dopamine in the nervous system. Adv. Neurochem.1, 247?299 (1975).","journal-title":"Adv. Neurochem."},{"key":"CR54","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.1972.03200090069022","volume":"220","author":"M. Stefanini","year":"1972","unstructured":"Stefanini, M., Hetherington, E. N.: Levodopa in hepatic failure. J. Amer. Med. Assoc.220, 1247 (1972).","journal-title":"J. Amer. Med. Assoc."},{"key":"CR55","unstructured":"Tolis, G, Lal, S., Pinter, E.: Reduced growth hormone responses to apomorphine and L-dopa in obesity (Symposium of the International Society of Psychoendocrinology, Vis\u00e9gard), pp. 335?339. Publishing House of the Hungarian Academy of Sciences. 1975."},{"key":"CR56","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1139\/y77-172","volume":"55","author":"D. Tsang","year":"1977","unstructured":"Tsang, D., Lal, S.: Effect of monoamine receptor agonists and antagonists on cyclic AMP accumulation in human cerebral cortex slices. Canad. J. Physiol. Pharmacol.55, 1263?1269 (1977).","journal-title":"Canad. J. Physiol. Pharmacol."},{"key":"CR57","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.39.12.1186","volume":"39","author":"D. Tsang","year":"1976","unstructured":"Tsang, D., Lal, S., Sourkes, T. L., Ford, R. M., Aronoff, A.: Studies on cyclic AMP in different compartments of cerebrospinal fluid. J. Neurol. Neurosurg. Psychiat.39, 1186?1190 (1976).","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"CR58","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0016-5085(79)90399-8","volume":"76","author":"M. Uribe","year":"1979","unstructured":"Uribe, M., Farca, A., Marquez, M. A., Garcia-Ramos, G., Guevara, L., Briones, A., Gil, S.: Treatment of chronic portal systemic encephalopathy with bromocriptine. A double-blind controlled trial. Gastroenterology76, 1347?1351 (1979).","journal-title":"Gastroenterology"},{"key":"CR59","first-page":"497","volume":"62","author":"A. Weiss","year":"1974","unstructured":"Weiss, A., Pitman, E. R., Javdan, P.: Arousal response in hepatic encephalopathy with L-dopa. Am. J. Gastroenterol.62, 497?503 (1974).","journal-title":"Am. J. Gastroenterol."},{"key":"CR60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1507\/endocrj1954.26.81","volume":"26","author":"K. Yamaguchi","year":"1979","unstructured":"Yamaguchi, K., Fukushima, H., Uzawa, H.: Response of human growth hormone, prolactin, and thyrotropin to thyrotropin releasing hormone in liver cirrhosis and diabetes mellitus. Endocrinol. Jap.26, 81?88 (1979).","journal-title":"Endocrinol. Jap."},{"key":"CR61","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jnnp.38.4.322","volume":"38","author":"S. N. Young","year":"1975","unstructured":"Young, S. N., Lal, S., Sourkes, T. L., Feldmuller, F., Aronoff, A., Martin, J. B.: Relationship between tryptophan in serum and CSF and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of the liver and probenecid administration. J. Neurol. Neurosurg. Psychiat.38, 322?330 (1975).","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"CR62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF01250597","volume":"47","author":"S. N. Young","year":"1980","unstructured":"Young, S. N., Lal, S.: CNS tryptamine metabolism in hepatic coma. J. Neural Transm.47, 153?161 (1980).","journal-title":"J. Neural Transm."},{"key":"CR63","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1210\/jcem-45-3-576","volume":"45","author":"A. Zanoboni","year":"1977","unstructured":"Zanoboni, A., Zanoboni-Muciaccia, W.: Elevated basal growth hormone levels and growth hormone response to TRH in alcoholic patients with cirrhosis. J. Clin. Endocr. Metab.45, 576?578 (1977).","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR64","first-page":"327","volume":"6","author":"L. Zieve","year":"1979","unstructured":"Zieve, L.: Hepatic encephalopathy: summary of present knowledge with an elaboration on recent developments. Progr. Liv. Dis.6, 327?341 (1979).","journal-title":"Progr. Liv. Dis."}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01243516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01243516\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01243516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T12:29:55Z","timestamp":1683030595000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01243516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,3]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1982,3]]}},"alternative-id":["BF01243516"],"URL":"https:\/\/doi.org\/10.1007\/bf01243516","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,3]]}}}